2.要約中間連結財務諸表及び主な注記

(1)要約中間連結財政状態計算書

 

 

 

(単位:千円)

 

前連結会計年度

(2023年12月31日)

 

当中間連結会計期間

(2024年6月30日)

資産

 

 

 

非流動資産

 

 

 

有形固定資産

5,238,673

 

5,852,597

使用権資産

814,513

 

1,039,450

のれん

17,261,275

 

19,738,788

無形資産

3,690,331

 

4,832,568

持分法で会計処理されている投資

360,821

 

433,608

繰延税金資産

304,436

 

238,751

その他の金融資産

3,793,224

 

5,990,704

その他の非流動資産

23,811

 

19,223

非流動資産合計

31,487,087

 

38,145,692

 

 

 

 

流動資産

 

 

 

棚卸資産

2,330,622

 

2,976,150

営業債権及びその他の債権

3,973,476

 

5,177,582

その他の金融資産

1,577,274

 

4,939,911

その他の流動資産

1,392,881

 

1,448,017

現金及び現金同等物

21,633,028

 

16,306,208

流動資産合計

30,907,282

 

30,847,870

資産合計

62,394,370

 

68,993,563

 

 

 

 

負債及び資本

 

 

 

非流動負債

 

 

 

借入金

1,600,000

 

1,400,000

リース負債

150,276

 

257,350

繰延税金負債

1,173,159

 

1,422,003

その他の金融負債

15,139,232

 

15,353,137

その他の非流動負債

85,146

 

79,952

非流動負債合計

18,147,815

 

18,512,444

 

 

 

 

流動負債

 

 

 

営業債務及びその他の債務

2,064,776

 

2,203,039

借入金

1,300,000

 

3,668,000

1年内返済予定の長期借入金

400,000

 

400,000

リース負債

249,158

 

294,648

未払法人所得税

2,187,700

 

1,218,991

その他の金融負債

49,010

 

1,099,386

その他の流動負債

1,943,131

 

2,032,755

流動負債合計

8,193,776

 

10,916,821

負債合計

26,341,592

 

29,429,265

 

 

 

 

資本

 

 

 

資本金

13,052,056

 

13,218,954

資本剰余金

7,397,974

 

6,480,860

自己株式

15,302

 

15,302

利益剰余金

8,790,563

 

9,120,690

その他の資本の構成要素

4,569,122

 

8,029,714

親会社の所有者に帰属する持分合計

33,794,414

 

36,834,916

非支配持分

2,258,363

 

2,729,380

資本合計

36,052,778

 

39,564,297

資本及び負債の合計

62,394,370

 

68,993,563

 

E0571221600株式会社ジーエヌアイグループGNI Group Ltd.四半期第7号参考様式 [IFRS](連結)(一般2Q)IFRStrueCTE2024-01-012024-06-30Q22024-12-312023-01-012023-06-302023-12-311falsefalsefalse216002022-12-31216002023-12-31216002023-01-012023-06-30216002023-06-30216002024-01-012024-06-30216002024-06-30216002024-08-14216002022-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002022-12-31jpigp_cor:ShareCapitalIFRSMember216002022-12-31jpigp_cor:CapitalSurplusIFRSMember216002022-12-31jpigp_cor:TreasurySharesIFRSMember216002022-12-31jpigp_cor:RetainedEarningsIFRSMember216002022-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember216002022-12-31jpigp_cor:ShareAcquisitionRightsIFRSMember216002022-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002022-12-31jpigp_cor:NonControllingInterestsIFRSMember216002023-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002023-12-31jpigp_cor:ShareCapitalIFRSMember216002023-12-31jpigp_cor:CapitalSurplusIFRSMember216002023-12-31jpigp_cor:TreasurySharesIFRSMember216002023-12-31jpigp_cor:RetainedEarningsIFRSMember216002023-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember216002023-12-31jpigp_cor:ShareAcquisitionRightsIFRSMember216002023-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002023-01-012023-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002023-01-012023-06-30jpigp_cor:ShareCapitalIFRSMember216002023-01-012023-06-30jpigp_cor:CapitalSurplusIFRSMember216002023-01-012023-06-30jpigp_cor:TreasurySharesIFRSMember216002023-01-012023-06-30jpigp_cor:RetainedEarningsIFRSMember216002023-01-012023-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002023-01-012023-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002023-01-012023-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002023-01-012023-06-30jpigp_cor:NonControllingInterestsIFRSMember216002023-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002023-06-30jpigp_cor:ShareCapitalIFRSMember216002023-06-30jpigp_cor:CapitalSurplusIFRSMember216002023-06-30jpigp_cor:TreasurySharesIFRSMember216002023-06-30jpigp_cor:RetainedEarningsIFRSMember216002023-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002023-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002023-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002023-06-30jpigp_cor:NonControllingInterestsIFRSMember216002024-01-012024-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002024-01-012024-06-30jpigp_cor:ShareCapitalIFRSMember216002024-01-012024-06-30jpigp_cor:CapitalSurplusIFRSMember216002024-01-012024-06-30jpigp_cor:TreasurySharesIFRSMember216002024-01-012024-06-30jpigp_cor:RetainedEarningsIFRSMember216002024-01-012024-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002024-01-012024-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002024-01-012024-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002024-01-012024-06-30jpigp_cor:NonControllingInterestsIFRSMember216002024-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002024-06-30jpigp_cor:ShareCapitalIFRSMember216002024-06-30jpigp_cor:CapitalSurplusIFRSMember216002024-06-30jpigp_cor:TreasurySharesIFRSMember216002024-06-30jpigp_cor:RetainedEarningsIFRSMember216002023-12-31jpigp_cor:NonControllingInterestsIFRSMember216002024-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002024-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002024-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002024-06-30jpigp_cor:NonControllingInterestsIFRSMember216002023-01-012023-06-30jpcrp_cor:ReportableSegmentsMember216002023-01-012023-06-30tse-scediffr-21600:PharmaceuticalReportableSegmentMember216002023-01-012023-06-30tse-scediffr-21600:MedicalDeviceReportableSegmentMember216002023-01-012023-06-30jpcrp_cor:ReconcilingItemsMember216002024-01-012024-06-30tse-scediffr-21600:PharmaceuticalReportableSegmentMember216002024-01-012024-06-30tse-scediffr-21600:MedicalDeviceReportableSegmentMember216002024-01-012024-06-30jpcrp_cor:ReconcilingItemsMember216002024-01-012024-06-30jpcrp_cor:ReportableSegmentsMemberiso4217:JPYxbrli:sharesiso4217:JPYxbrli:pure